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This project set out to test the feasibility and acceptability of the Moving On In My 
Recovery (MOIMR) programme.  MOIMR is a 12-session, acceptance-based 
cognitive behavioural group programme that was co-produced and is co-facilitated 
by treatment professionals and service users in recovery (Hogan, 2016).  The 
primary aim of MOIMR is to bridge the gap between formal treatment provision and 
mutual aid (i.e., to assist service users who have attained a period of abstinence in 
treatment to access wider mutual aid). 
Sixty-one participants were recruited from six group programmes hosted by BCUHB 
substance misuse services and the North Wales Recovery Community.  Aside of 
assessing feasibility for a larger randomised controlled trial, study aims were to 
determine whether participants experienced improvements in terms of their 
psychological flexibility and wellbeing.  Participants completed baseline 
questionnaires prior to starting the group programme, immediately following the last 
group session (12-weeks after baseline), and then again, at a further 3-month follow 
up; at the two follow-up sessions participants completed the baseline questionnaires 
and took part in a focus group.  Participants who dropped out of the group 
programme were also contacted at the follow-up time-point and they were 
interviewed about their experience.   
The study confirmed that a larger randomised controlled trial (RCT) to evaluate the 
effectiveness of Moving On In My Recovery would be viable. Using predetermined 
criteria, it was established that recruitment was feasible, that the study measures 
were suitable and they were completed satisfactorily.  Attrition (at 52%) was higher 
than anticipated although possibly at a level that is reasonable for this population 
and an intervention of such intensity.  The ecological validity of the intervention itself 
was high:  participants reported that the intervention had a profound effect on their 
lives and the skills they acquired had led to improvements in confidence, self-
esteem, communication and in many other ways.  Significant improvements in 
recovery capital, mood and anxiety were shown at the end of the group programme 
and these were sustained at a three-month follow-up; psychological flexibility and 
social functioning was significantly improved at the three-month follow-up.  Three-
month abstinence rates improved from 55% at baseline to 62% at post-group to 68% 
at a three-month follow-up.  Follow-up interviews with seven participants who 
dropped out of the programme yielded insufficient data for analysis.  
The service users’ perspective of the intervention was highly positive.  All of the 
participants who were interviewed praised the programme highly, and some of those 
who dropped out indicated that they intended to join a group in the future.  The 
participants particularly valued the co-facilitation of groups by people with lived 
experiences.  Interestingly, many participants described their initial reluctance to 
attend a group-based intervention, but also how this resistance lifted as they became 
more comfortable in the group setting.  Participants described being on a shared 
journey with other group members and even with the facilitators.  It seems that the 
structure and framework of the group was something that had been missing from the 
lives of the people struggling with addiction.  The group made profound impacts on 
the participants’ lives, and many felt it should be more widely available and as a form 
of continuous support for people in recovery.  In short, participants were transformed 




Drug misuse is a global crisis:  the United Nations Office on Drugs and Crime (World 
Drug Report, 2020) estimated that in 2018 more than a quarter of a billion people 
used drugs, with 35.6 million people suffering with drug use disorders.  There is no 
doubt that in the United Kingdom we also have a serious substance misuse problem:  
in the latest statistics more than 250,000 people accessed treatment services in 
2018/2019, which had increased by 4% from the previous year (Office of National 
Statistics, 2019).  These statistics show that opiate users represented the majority of 
people in treatment at 52%; however, alcohol represents a growing concern for 
treatment services with 60% of new referrals reporting primary concerns with 
alcohol.  Of the estimated 586,797 people believed to be dependent on alcohol in 
England, just 18% accessed treatment.  
Substance dependence represents a leading cause of premature mortality 
(Degenhardt et al., 2013), and it is the fifth highest cause of preventable deaths in 
the UK (ONS, 2018); of course, it also contributes to the other leading causes of 
preventable deaths, like cancer, cardiovascular disease, injuries and respiratory 
disease.  Substance dependence is also associated with mental health difficulties, 
with over half of the people who enter treatment reporting co-morbid mental health 
problems (ONS, 2019).  
Treatment services have had limited effectiveness in providing sustained recovery 
for service users.  For example, of the 120,000 people who exited treatment in 
2018/2019, less than half (approximately 57,000) managed to leave treatment 
successfully (ONS, 2019).  A recent study by Hogan, Jabeen, Race and Rettie 
(2018) found that 83% of individuals who accessed treatment at a detoxification unit 
in the UK successfully completed their pharmacological detoxification.  Despite these 
promising completion rates and continuous improvements in these services, relapse 
rates after treatment are still very high.  Relapse rates post-detoxification for alcohol 
dependency are between 60% and 90% and are believed to be higher for other 
drugs (Aguiar, Neto, Lambaz, Chick, & Ferrinho, 2012; Becker, 2008; Raistrick, 
Heather, & Godfrey, 2006; Spada, Nuamah, Luty, & Nikcevic,2008).  A multitude of 
factors can determine relapse, including a lack of coping mechanisms, interpersonal 
problems, low self-efficacy and maladaptive motivation (Marlatt & Donovan, 2005; 
McKay, 1999).  
It is evident that recovery from addiction does not end once a patient has left these 
treatment services (Drug Strategy, 2010; Welsh Assembly Government, 2013).  The 
recovery movement has recognised the complexities of addiction, and it purports that 
recovery is a process that takes years to complete (Best & Laudet, 2010; Laudet, 
2007; Welsh Assembly Government, 2013).  As a result of this change in 
perspective, there is a new focus in both research and practice on the concept of 
recovery (Best & Laudet, 2010; Drug Strategy, 2015). 
There is now a diverse range of mutual aid groups available within the UK (Drug 
Strategy, 2017; Humphreys, 2004).  Recovery research has focused on the 
effectiveness of, and involvement in, traditional 12-step groups, such as Alcoholics 
Anonymous (AA; Pagano, White, Kelly, Stout, & Tonigan, 2013) or other well-
established mutual aid group, such as SMART Recovery (Campbell, Hester, 
Lenberg, & Delaney, 2016).  These groups have received support in the literature, 
with group involvement in both SMART and AA associated with greater levels of 
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abstinence than without this involvement (Campbell et al., 2016; Pagano et al., 
2013).  Despite the effectiveness of, and the rise in, mutual aid groups, there has 
been a barrier from treatment providers supporting the transition to mutual aid (Best 
et al., 2016), mainly due to clinicians’ negative attitudes to mutual aid. 
In order to bridge the gap between treatment services and mutual aid, it is essential 
to improve the chances of long-term, sustained recovery for people with substance 
use disorders.  The Moving On In My Recovery programme (Hogan, 2016) was 
specifically designed to provide the necessary skills to support recovery and to 
bridge the gap from treatment to sustained recovery.  
The introduction of ‘third wave’ therapies has led to new developments in the 
treatment of substance use disorders.  These approaches use mindfulness and 
acceptance-based strategies to reduce the likelihood that internal triggers (i.e., 
thoughts, emotions, memories) will lead to substance use (Lee, An, Levin, & Twohig, 
2015).  Acceptance and Commitment Therapy (ACT) has shown promising 
effectiveness for those with comorbid substance use disorders and mental health 
problems (see Bowen et al., 2009; Witkiewitz, Bowen, Douglas, & Hsu, 2013).  
Within the ACT framework, substance use is seen as a form of ‘experiential 
avoidance’ (Hayes, Wilson, Gifford, Follette, & Stroshal, 1996), whereby individuals 
use substances to avoid unwanted thoughts, feelings and physiological experiences.  
The Moving On In My Recovery group programme uses the underlying ACT model in 
combination with service users’ lived experiences:  it combines evidence-based 
strategies with co-production.  Co-production has also been shown to be an effective 
component of psychological interventions for substance use disorders (Park, 2020).  
Aims 
The primary aim of this project was to test the feasibility and acceptability of the 
Moving On In My Recovery programme.  Secondary aims were to determine whether 
participants experienced improvements in terms of their psychological flexibility and 
wellbeing.  
Inevitably, some participants do not start group programmes or drop out of them 
early.  Little is known about these people or those who decline to engage in wider 
mutual aid.  This project aimed to fill these gaps in our knowledge by (a) answering 
questions about why this might happen and (b) helping us to identify further ways to 
support people in treatment. 
We hypothesized that from baseline to the post-group time point psychological 
flexibility would increase, and improvements in psychological wellbeing and 
functioning would also occur.  We also anticipated that these gains would be 
maintained at the three-month follow-up.   
In keeping with the original design and delivery of MOIMR, we wished to retain direct 
service-user involvement in conducting this study.  Thus, we utilized a volunteer peer 
to help to collect data and to co-facilitate the semi-structured focus groups at the 
post-group and follow-up points.   
We aimed to eliminate or at least reduce any bias caused by participants’ agreement 
to take part in this study.  To that end, we paid all participants (whether they dropped 
out of treatment or they remained committed to attending MOIMR groups) for their 
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participation.  All participants earned £5 for completing the standard set of pre-
assessment measures; they earned £10 for completing the set of post-group 
assessment measures and undertaking an interview (i.e., a focus group for MOIMR 
‘completers’ or an individual interview for MOIMR ‘dropouts’); all participants earned 
£10 for completing the set of 3-month follow-up assessments and undertaking an 
interview.  
Moving On In My Recovery 
Moving On In My Recovery (MOIMR) is a 12-session, acceptance-based cognitive 
behavioural group programme that was co-produced and is co-facilitated by 
treatment professionals and service users in recovery (Hogan, 2016).  The primary 
aim of MOIMR is to bridge the gap between formal treatment provision and mutual 
aid (i.e., to assist service users who have attained a period of abstinence in 
treatment to access wider mutual aid); the MOIMR programme itself, however, has 
become its own form of mutual aid, with many group participants going on to develop 
their own legacy Moving On In My Recovery groups after completing the MOIMR 
programme.  
The MOIMR programme was initially developed from Welsh Government grant 
funding in 2014.  The developers of the programme asked more than 100 people in 
recovery and clinicians working with substance users two questions:  (a) what topics 
were important to discuss when service users were leaving treatment services and 
(b) what strategies and techniques helped them the most?  The programme covers 
many topics related to mental wellbeing and substance misuse (e.g., dealing with 
loss, stigma, shame, anxiety, depression, and relapse; see Appendix A for a full list 
of these topics).  All topics and strategies used are based on psychological theory 
and are evidence-based techniques that have been shown to work in practice. The 
programme adopts an underlying psychological model aligned to Acceptance and 
Commitment Therapy (ACT).   
ACT-based therapies are intended to enhance psychological flexibility.  
Psychological flexibility is a person’s capacity to maintain awareness of (and 
acceptance of) their present state, without attempting to control or avoid unpleasant 
or aversive internal experiences (Hayes, Luoma, Bondm Masuda, & Lillis, 2006).  
The pursuit of a richer and more meaningful life can be achieved when one is open 
to (and accepting of) distressing internal experiences as one moves in the direction 
of personal values (Kashdan & Rottenburg, 2010).  In direct opposition to this stance 
is experiential avoidance, whereby an individual gives up on the pursuit of 
meaningful activities as result of distressing internal experiences, which ultimately 
leads to greater suffering (Hayes et al., 2006).  
In order to enhance psychological flexibility, the MOIMR programme includes a 
weekly challenge.  This process encourages participants to make contact with 
difficult experiences and to approach them with curiosity. The programme refers to 
this process as “leaning in”.  Participants are encouraged to explore experiences as 
they are directly felt in a mindful way.  Challenges are typically based on the weekly 
topics discussed in each session, but they are broadly related to participating in 
activities in support of recovery or the enhancement of wellbeing (e.g., doing gentle 
exercise, reading a book chapter, writing in a journal, contacting a friend, doing 
something that has been postponed because it feels aversive). 
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Besides ‘leaning in’, the programme follows a second main principle called ‘letting 
go’.  Letting go draws on the ACT-based principles of diffusion from attention 
capturing cognitions and emotions.  Participants are encouraged to let go of 
unhelpful thoughts, memories and internal content through fostering acceptance of 
these difficult experiences.  Letting go is a particularly challenging task and typically 
develops slowly following group discussion of difficult and challenging experiences.   
The programme also includes a weekly check-in.  The check-in provides an 
opportunity to discuss the participants’ progress and the outcome of the challenge 
set from the previous week.  It also helps to establish connections among the 
participants and for them to be able to hear about others’ personal ongoing 
experiences.  In order to further consolidate the learning, at the check-in facilitators 
also tend to highlight the skills and topics learned during the programme.  
Each group session takes approximately two hours to complete.  The first 45 
minutes to 60 minutes is dedicated to the check-in.  This is typically followed by a 10-
minute comfort break.  The next 45 minutes is dedicated to exploring a specified 
topic, which is presented on PowerPoint slides via a projector.  The programme uses 
a highly professional set of images that depict a number of psychological concepts, 
often by using metaphors or stories to explore each topic.  Discussion is encouraged 
throughout.  A further 5 minutes is dedicated to setting a weekly challenge for each 
individual.  These challenges are specific, measurable, achievable, realistic and 
timely.  The facilitator records them, so that they are ready for the next week’s 
check-in.  Following the group, the facilitators spend 15 minutes debriefing the 
session by following a debrief guide (see Appendix B).        
Method 
Participants    
The study recruited 61 participants who attended 6 separate MOIMR groups.  There 
were 39 (64%) males and 22 (36%) females.  The mean age of participants was 43 
years-old (Range 23 to 67).  Alcohol was the primary drug of concern for 37 (61%) 
participants, heroin for 16 (26%) participants, cocaine for 5 (8%) participants and 
‘other’ (amphetamine, ketamine) for 3 (5%) participants.  At the time of entry into the 
study, 54% of the sample had been abstinent from substances in the previous three 
months. 
A total of 29 participants (48%) completed the MOIMR programme and the first post-
group follow-up, and 25 participants (41%) completed the three-month follow-up.  







Table 1. Number of Participants Recruited into the Study by Group Location and 





(n = 69)  
Recruited 
Participants  
(n = 61)  
Post-group 
Follow-up 
(n = 29) 
3-month Follow-up 
(n = 25)  
Bangor 1 15 13 7 (54%) 7(54%) 
Caernarfon 7  7  1 (14%) 0 (0%) 
Colwyn Bay 13  11  7 (64%) 6 (55%) 
Rhyl 8 8 3 (38%) 1 (13%) 
Shotton 16 14 6 (43%) 6 (43%) 
Bangor 2 10 8 5 (63%) 5 (63%) 
 
Ethical Approval 
Ethical approvals were obtained from Bangor University School of Psychology Ethics 
Committee and the Integrated Research Application System.  The study was 
registered with Betsi Cadwaladr University Health Board Research & Development 




The study employed quantitative methods (i.e., a within-participants repeated-
measures design) over three time points (i.e., baseline, post-group, and a three-
month follow-up). The study also employed qualitative methods (i.e., two focus 
groups for each separate group at the post-group and three-month follow-up time 
points).  Feasibility was assessed using pre-determined criteria (see Table 2.). 
 
Instruments 
The Recovery Strengths Questionnaire (RSQ; Hogan, 2016) is a 15-item self-report 
questionnaire. It assesses five dimensions of recovery capital (social strengths, 
physical strengths, activity strengths, personal strengths and attitudinal strengths).  
Respondents record their current satisfaction on a 0 (not at all satisfied) to 10 (totally 
satisfied) scale.  The measure assesses strengths derived from attending mutual aid 
support (i.e., internally generated recovery capital) and strengths derived from the 
wider community (i.e., externally generated recovery capital). Cronbach’s alpha 
showed that reliability for the scale is α = .93 (see Rettie, Hogan, & Cox, 2018).  
 
Patient Health Questionnaire (PHQ-9; Kroenke, Spitzer, & Williams, 2001) is a 9-
item questionnaire designed to measure low mood and depression. This measure 
also contains validated clinical norms. Respondents self-report the frequency of 
various clinically significant symptoms during the past two weeks on a four-point 
Likert scale ranging from 0 (Not at all) to 3 (Nearly every day).  Internal reliability was 
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found to be high (Cronbach’s alpha = .89) and test-retest reliability was .84 
(Kroenke, Spitzer & Williams, 2001).   
 
General Anxiety Disorder (GAD-7; Spitzer, Kroenke, Williams and Löwe, 2006) is a 
7-item questionnaire designed to assess level of anxiety. This measure also contains 
validated clinical norms. Respondents self-report the frequency of various clinically 
significant symptoms during the past two weeks on a four-point Likert ranging from 0 
(Not at all sure) to 3 (Nearly every day).  The GAD – 7 was found to have high 
internal consistency (Cronbach’s alpha α = .92) and a high test-retest score of .83. 
 
General Health Questionnaire (GHQ 12; Goldberg & Williams, 1988) is a 12-item 
questionnaire designed to assess mental health and social functioning.  It is a 
shorter version of the original 60-item General Health Questionnaire (GHQ 60; 
Goldberg, 1972). Items are rated on a 4-point scale (e.g., from 1 “Better than usual” 
to 4 “Much less than usual” or 1 “Not at all” to 4 “Much more than usual”). Higher 
scores on the questionnaire indicate poorer mental health. Example items are “Have 
you recently lost much sleep over worry?”, “Have you recently been thinking of 
yourself as a worthless person?”. Cronbach’s alpha has shown that the reliability of 
this scale is α =. 93 (see Levin et al., 2012). 
 
Brief Experiential Avoidance Questionnaire (BEAQ; Gámez et al., 2014) is a 15-item 
questionnaire.  It is a brief version of the original 62-item Multidimensional 
Experiential Avoidance Questionnaire (MEAQ; Gámez, Chmielewski, Kotov, 
Ruggero, & Watson, 2011). The BEAQ is designed to assess experiential avoidance.  
Items are rated on a 6-point scale (e.g., from 1 “strongly disagree” to 6 “strongly 
agree”). Higher scores indicate elevated levels of experiential avoidance. Example 
items are “When unpleasant memories come to me, I try to put them out of my way” 
and “I rarely do something if there is a chance that it will upset me”. Cronbach’s 
alpha shows that the BEAQ has good internal consistency (α =. 93). 
 
Acceptance and Action Questionnaire–Substance Abuse (AAQ-SA; Luoma, Drake, 
Kohlenberg, & Hayes) is an 18-item scale containing two subscales: (a) Values 
Commitment, and (b) Defused Acceptance. It measures psychological flexibility in 
relation to substance use related thoughts, feelings, and urges. The focus of the AAQ-
SA is on one's relationship to or the functions of private events, versus the content of 
the events themselves. Cronbach’s alpha has shown that internal consistency for this 
scale is α =. 85. 
 
Procedure 
Participants eligible to take part in the study were those who had enrolled on a 
Moving On In My Recovery (MOIMR) group programme within Betsi Cadwaladr 
University Health Board (BCUHB) Substance Misuse Services and the partner 
recovery organisation North Wales Recovery Communities.  Group members were 
informed about the study at a welcome event, which was held prior to the start of the 
group programme.  Participants then arranged to meet the research team1 prior to 
the start of Session One of the MOIMR programme.  Participants were paid £5 for 
completing the pre-group (baseline) questionnaires. 
 
 
1 In keeping with the original MOIMR design and philosophy, each interview was supported by a person in 
recovery (i.e., with lived experience of addiction). 
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Following the last group session (i.e., week 12) of the group programme, participants 
were again asked to complete the baseline questionnaires and to undertake a focus 
group interview (see Appendix C for the interview schedule) about their experiences 
of the group programme. Participants were paid £10 for their time.  At this time point, 
all participants who had failed to complete the group programme were contacted to 
arrange a time for them to attend an interview and to complete the baseline 
questionnaires again. They were also paid £10 for their time. 
 
Three-months from the last group session, participants were again asked to 
complete the same baseline questionnaires and to undertake a focus group interview 
about their experiences since completing the group programme; participants were 
again paid £10 for their time.  Participants were then thanked and debriefed about 
the study.     








Five feasibility outcomes were assessed in this study. The study used predetermined 
criteria (see Table 2) to assess feasibility.   
 
1 The recruitment rate was 88% and therefore greater than the predetermined level 
(i.e., the green criterion was recruitment greater than 80%) and therefore 
acceptable:  of the 69 people who enrolled in the 6 MOIMR group programmes, 
61 people participated in the study.   
2 The retention rate at the post-group time-point was 48%; therefore, it did not 
meet the predetermined level (i.e., the green criterion was that more than 60% of 
the sample would be retained in the study).  The retention rate did partially meet 
the requirement (i.e., it fell within the amber criterion of 45% to 59%). Of the 61 
participants who started the study, 29 were retained at the first follow-up time 
point.   
3 The retention rate at the three-month follow-up was 41%; therefore, it did not 
meet the predetermined level (i.e., the green criterion was that more than 50% of 
the sample would be retained in the study at the three-month follow-up).  The 
follow-up retention rate did partially meet the requirement (i.e., it fell within the 
amber criterion of 40% to 49%):  of the 61 participants, 25 were retained at the 
three-month follow-up.   
4 The quality of completed questionnaire data was high at 95% (e.g., that is 
completed questionnaires without missing data) and therefore was at the 
predetermined level (i.e., the green criterion was that greater than 90% of data 
sets would be complete). 
5 The follow-up rate of those dropping out of the MOIMR group programme was 
22%; therefore, it did not meet the predetermined level (i.e., the green criterion 
was that more than 50% of the sample who dropped out would be retained in the 
study at the post-group follow-up); n = 7 participants who dropped out of the 
MOIMR group were contacted at the follow-up time point; therefore, it met the red 
criterion (i.e., feasibility would not be demonstrated if fewer than 30% of the 
group participants who dropped out of the group could not be contacted at follow-





Table 2. Pre-determined Feasibility Criteria 
Criterion Critical Feasibility 
Outcome 
Proposed Thresholds on Critical Outcome Outcome 
1. Recruitment rate The number of group 
participants consenting 
to take part in the study 
     Feasibility will be demonstrated if 80% or more of group participants consent to take part in the study. 
     Feasibility will be partially demonstrated if 50% of participants consent to take part in the study:  future 
recruitment is possible but additional recruitment strategies will be necessary. 
     Feasibility will be partially demonstrated if less than 50% of participants consent to take part in the study then 
feasibility is not demonstrated. 
    From a total of 69 
participants who attended 
the groups 61 (88%) 
consented to participate. 
2. Study retention The number of group 
participants retained in 
the study 
     Feasibility will be demonstrated if 60% or more of group participants are retained at follow-up. 
     Feasibility will be partially demonstrated if 45% to 59% of group participants are retained at follow-up. 
     Feasibility will not be demonstrated if less than 45% of group participants are retained at follow-up. 
    From a total of 61 
participants who attended 
the groups 29 (48%) 
completed the follow-up 
session. 
3. Study follow-up The number of group 
participants retained at 
the three-month follow-
up 
     Feasibility will be demonstrated if 50% or more of group participants are retained at the three-month follow-
up. 
     Feasibility will be partially demonstrated if 40% to 49% of group participants are retained at the three-month 
follow-up. 
     Feasibility will not be demonstrated if less than 40% of group participants are retained at the three-month 
follow-up. 
    From a total of 61 
participants who attended 
the groups 25 (41%) 
completed the three-month 
follow-up. 
4. Data quality 
checklist 
The amount of missing 
data from completed 
questionnaire 
     Feasibility will be demonstrated if more than 90% of participant questionnaires are fully completed. 
     Feasibility will be partially demonstrated if 80% to 89% of participant questionnaires are fully completed. 
     Feasibility will not be demonstrated if less than 80% of participant questionnaires are fully completed. 
     95% of all questionnaires 






dropped out of the 
groups contacted at 
follow-up  
     Feasibility will be demonstrated if 50% or more of group participants that drop out of the group are contacted 
at follow-up. 
     Feasibility will be partially demonstrated if 30% to 49% of group participants that drop out of the group are 
contacted at follow-up. 
     Feasibility will not be demonstrated if less than 30% of group participants that drop out of the group are 
contacted at follow-up. 
     22% (n = 7) of 
participants who dropped 




Baseline Data (Completer versus Non-Completers) 
There were no apparent differences between those who were retained in the study 
(Completers) and those who dropped out (Non-Completers).  For example, the 
Completers group (n = 29) had n = 18 males and n = 11 females and the Non-
Completers group (n = 32) had n = 21 males and n = 11 females.  The average age 
of the Completers was 44 years old (Range = 23 to 67) and for the Non-Completers, 
it was 43 years old (Range = 25 to 66).  The proportion of primary drugs of concern 
was very similar in the two groups:  Completers versus Non-Completers, 
respectively, were Alcohol: 49% versus 51%; Heroin: 27% versus 25%; Cocaine: 3% 
versus 13%; and for ‘other drug’ it was 7% versus 3%.  The three-month abstinence 
rate prior to the study was 55% for the Completers and 53% for the Non-Completers.  
There was no significant difference between the Completers and the Non-
Completers on any of the baseline measures (see Table 3.). 
 
Table 3. Mean Baseline Questionnaire Scores and Standard Deviations for 
Completers and Non-Completers.    
Questionnaire 
Completer 
M (sd)  
Non-Completer 
M (sd)  
Recovery Strengths (RSQ) 86.7 (25.2) 88.5 (25.4) 
Low Mood (PHQ-9)  15.1 (7.9) 15.8 (7.1) 
Anxiety (GAD-7)  13.2 (6.4) 14.2 (5.9) 
Social Functioning (GHQ-12) 5.6 (4.4) 5.7 (4.4) 
Values (AAQ-SA) 43.3 (7.0) 44.5 (9.6) 
Acceptance (AAQ-SA) 32.4 (12.5) 28.2 (10.3) 
Experiential Avoidance (BEAQ) 59.0 (14.8) 59.6 (14.4) 
*Note: All differences were non-significant. 
  
Main Quantitative Outcomes 
Recovery Strengths:  A repeated-measures ANOVA showed a significant effect for 
time, F(1,48) = 16.8, p < .001.  After Bonferroni corrections, Recovery Strength was 
still significantly lower at baseline [M = 85.1 (sd = 23.8)] than at either of the follow-
up time points:  post-group: M = 100.8 (sd = 22.8), p < .01, and at the 3-month 




Figure 1. Recovery Strengths at Baseline, Post-Group Completion and at a 3-Month 
Follow-up. 
Low Mood:  Repeated Measures ANOVA showed a significant effect for time, 
F(1,48) = 11.4, p < .001.  Bonferroni tests showed that Low Mood was significantly 
higher at baseline [M = 15.6 (sd = 7.4)] than at either of the follow-up time points:  
post-group M = 11.3 (sd = 6.3), p < .01 and at the 3-month follow-up M = 9.1 (sd = 
7.9), p < .001 (see Figure 2.).   
   





Anxiety:  A repeated-measures ANOVA showed a significant effect for time, F(1,48) 
= 14.0, p < .001.  Bonferroni tests showed that Anxiety was significantly higher at 
baseline [M = 13.5 (sd = 5.9)] than at either of the follow-up time points:  post-group 
M = 9.0 (sd = 5.7), p < .01 and at the 3-month follow-up M = 7.9 (sd = 6.6), p < .01 
(see Figure 3.).   
 
Figure 3. Mean Scores of Anxiety at Baseline, at Group Completion and at a 3-
Month Follow-up. 
 
Social Functioning:  A repeated-measures ANOVA showed a significant effect for 
time, F(1,48) = 6.5, p < .01.  Bonferroni tests showed that Social Functioning was 
significantly more impaired at baseline [M = 17.6 (sd = 9.4)] than at the 3-month 
follow-up [M = 11.5 (sd = 7.8), p < .05]; however, the difference at the post-group 




Figure 4. Mean Scores of Impaired Social Functioning at Baseline, at Group 
Completion and at a 3-Month Follow-up. 
 
Values:  A repeated-measures ANOVA showed a significant effect for time, F(1,48) = 
4.2, p < .05.  Bonferroni tests showed that connection to values significantly 
increased from baseline, [M = 43.8 (sd = 6.0)] to the post-group follow-up [M = 48.4 
(sd = 7.9), p < .05]; however, at the 3-month follow-up it was a non-significant 
difference [M = 47.6 (sd = 9.5), p > .05] (see Figure 5.).   
 
Figure 5. Mean Scores of Connection to Values at Baseline, at Group Completion 




Acceptance:  A repeated-measures ANOVA showed a non-significant effect for time, 
F(1,48) = 3.1, p > .05.  There was no difference from baseline [M = 31.8 (sd = 11.2)] 
to the post-group follow-up [M = 38.0 (sd = 13.5)] nor to the 3-month follow-up [M = 
37.8 (sd = 13.7)] (see Figure 6.).   
 
Figure 6. Mean Scores of Acceptance at Baseline, at Group Completion and at a 3-
Month Follow-up. 
 
Experiential Avoidance:  A repeated-measures ANOVA showed a significant effect 
for time, F(1,48) = 4.7, p < .05.  Bonferroni tests showed that Experiential Avoidance 
was significantly greater at baseline  [M = 59.9 (sd = 14.7)] than at the 3-month 
follow-up [M = 53.6 (sd = 13.1), p < .05] however, it was a non-significant difference 




Figure 7. Mean Scores of Experiential Avoidance at Baseline, at Group Completion 
and at the 3-Month Follow-up. 
 
Abstinence rates across the three timepoints are shown in Figure 8.  At Baseline, 
55% of participants had been abstinent during the previous three-months; at Post-
group, 62% of participants had been abstinent during the previous three-months; and 
at the 3-month follow-up 68% of participants had been abstinent during the previous 
three-months.      
 
 
Figure 8. Percentage of Persons With Three Months or More of Abstinence at 

















The focus group interviews were audio recorded. The recordings were then 
transcribed and analysed by following the six-phase approach to Thematic Analysis 
(Braun & Clarke, 2012). The following steps were taken: (1) the research group 
familiarised themselves with the data by reviewing the transcripts of the focus groups; 
(2) initial codes were generated from the data; (3) themes were searched in the 
transcripts; (4) potential themes that best represented the codes and the data overall 
were selected; (5) themes were defined and named as clearly as possible; and finally 
(6) a report was written about the thematic analysis of the data.  Analysis revealed 
four main themes in the transcripts of the focus groups. The themes in the transcript, 
the codes assigned to them, and examples of the codes that are direct quotes from 
the participants are listed below. 
 
Theme 1:  The Challenges and Benefits of Attending MOIMR  
 
Many participants described an initial reluctance to attend a group-based programme.  
They reported downplaying the group’s effectiveness or their own need to participate.  
This initial reluctance was, however, balanced against the participants’ need to work 
on their recovery within the structure that MOIMR provided.  The codes and examples 
of these codes are as follows: 
 
i. An initial reluctance to attend: 
“I was the biggest sceptic.”  
“I just didn’t want to do it.” 
“I dreaded it.” 
“I was not keen on groups.” 
 
ii. The importance of structure: 
“It had a structure that kept me focused.” 
“The structure is a big help.” 
“It has a framework.”  
“Each week there is a focus on a theme. . . other mutual aid groups don’t do that.” 
“The structure is a big help.” 
Theme 2:  Realising that I am not alone  
 
A very strong theme was the sense that prior to entering the programme many people 
felt alone and isolated in their recovery from addiction.  Other people in the group 
impacted on the participants and there was a sense of a shared journey.  The group 
deepened participants’ ability for perspective-taking.  Co-facilitation by people with 
lived experience was also highly valued.  The codes and corresponding examples are 
as follows: 
  
i. The impact of others in the group: 
“I realised that I am not alone.”  
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“It was good to be involved with other people, you know, sharing, talking and hearing 
other people.”  
“I just thought there was something wrong with me. . ..  I have come to realise I can’t 
help the way I feel and I should accept that it is okay to feel this. . ..No one judged me.  
In this group I was just accepted for me, who I was, so that I have a problem but that 
problem doesn’t define me. . ..I’ve learned not to control my thoughts but to go with 
them. . .. It helped me to stop hating yourself as much for what you had done. . ..  
Moving On helped me see the bigger picture.” 
 
ii. A shared journey: 
“No one judged me. I was accepted for who I was.”  
“To have people who have been there and done it. . .relatable.”  
“I made real friendships.”  
“It was an opportunity to really discuss ideas and topics.” 
“You know you are not on your own and we all moved on together.” 
 
Theme 3:  The impact of MOIMR  
 
Many participants described how MOIMR had impacted them in unexpected ways.  
They learned specific skills to cope with cravings and urges, to lean into discomfort 
and to let go of painful thoughts and memories.  The programme also helped 
participants to learn about themselves. 
 
i. The impact of the group on recovery: 
“It shocked me back to life.” 
“From being the biggest sceptic. I was totally shocked by the impact.” 
“The change in me is quite amazing.” 
“It gave me knowledge, wisdom, and power.”  
“Feeling like I want to get up and go.” 
“It has improved my self-esteem.” 
“You learn a lot about yourself.” 
“It has had a profound effect.” 
“There is no hiding.” 
 
 
ii. The skills acquired from the group: 
“Leaning in – I‘d spent my whole life leaning out – avoiding.” 
“Dealing with emotions—loss” 
“Looking at myself.”  
“It has given me confidence—I can talk in groups.” 
“I have come out of my shell.” 
“I can tackle my problems head on.” 
“It has given me discipline, focus.” 
“I am communicating and that is massive for me.” 
“Relationships.” 




Theme 4:  Additional considerations for MOIMR  
 
Many participants described MOIMR as not being a course that could simply just one 
time.  In fact, many participants advocated that it should be done more than once.  A 
frequent observation was that the participants did not want to see the course come to 
an end.  Realising they would not have the group to attend was a particularly difficult 
experience for them. 
 
i. The need to do it more than once: 
“You need to do it more than once.” 
“I’ve done the course three times and you learned more each time you do it.” 
“It’s like the first time you’re not ready and then the second or even third time it comes 
together, you know?” 
“I did the course a couple of times, because you tend to do it more than once to really 
get all the other gen [sic] and benefit from it as well.” 
 
ii. A need to continue with recovery: 
“It has to lead on to something.”  
“I really looked forward to a Tuesday and for it not to be there was really difficult.” 
“It has got to lead on to something.” 
“Just do it nationwide. Do it nationwide, and you’ll probably see a rise in addicts 
become . . . I didn’t know about any of this.  All I knew about was CAIS and counselling 
and the NA group.  But then since I’ve had an option to re-structure my life again . . 
.Moving On In My Recovery . . . It just needs to be more nationwide so people that 
have been there and doing what we have done can also have the opportunity if they 
want it.” 
 
Non-Completers of MOIMR 
 
A total of 7 participants who dropped out of the study were available to be contacted 
at the post-group follow-up stage (i.e., 12 weeks after the baseline interview).  
Pairwise comparisons showed that the drop-outs had marginal improvements across 
time on the Recovery Strengths Questionnaire from baseline, M = 79.1 (sd = 20.4), 
to the follow-up, M= 88.4 (sd = 20.2); on the PHQ-9 from baseline, M = 18.9 (sd = 
4.8), to the follow-up, M = 14.1 (sd = 5.6); on the GAD-7 from baseline, M = 17.1 (sd 
= 3.5), to the follow-up, M= 14.1 (sd = 5.5); and on the BEAQ from baseline, M = 
53.6 (sd = 16.4), to the follow-up, M= 54.3 (sd = 13.4).  Despite the improvement that 
the follow-up scores suggested, they were largely equivalent to the baseline scores 
of the entire sample.   
 
Due to the drop-outs’ high levels of intoxication, the qualitative interviews with them 
yielded unsuitable transcripts for analysis.  In general, the participants who were 
interviewed described not being at a stage in their recovery where they were ready 
for the intervention:  two of them reported how they were still using heroin; another 
had been made homeless.  In some cases, participants described how they attended 
the group programme to “to get on prescription quicker for the withdrawals” and to 





This study sought to establish whether a larger randomised controlled trial (RCT) to 
evaluate the effectiveness of Moving On In My Recovery would be viable.  We have 
reached the conclusion that a RCT would indeed by feasible, and we recommend 
that it be carried out.  We reached this conclusion on the basis of (a) the ease with 
which the feasibility study was executed, and (b) the promising outcomes that it 
yielded for the participants who completed this study.  Of course, we cannot be sure 
that the improvements in participants’ lives demonstrated in this study can be 
attributed solely to the intervention or whether another intervention would bring 
equivalent or possibly better outcomes.  A RCT would allow us to draw these 
additional conclusions. 
 
The study recruited participants from ‘real-world’ treatment services.  We aimed to 
recruit 80% of the service users who were accessing the Moving On In My Recovery 
programme and this target was easily surpassed in that we recruited 85% of the 
targeted participants.  We were unable to screen the individuals who were recruited 
for their suitability for the intervention itself, as these decisions had already been 
made by the treatment services.  The attrition from the study was high at 52%.  A 
recent systematic review and meta-analysis of dropout rates in psychosocial 
interventions for substance use by Lappan, Brown and Hendricks (2020) found the 
average drop-out rate was around 30%.  Lappan et al. did, however, find that drop-
out rates were higher for dependent users than non-dependent users, higher in 
group programmes than individual interventions, and higher in interventions that had 
more than seven sessions or lasted more than 90-minutes.  All of these things 
characterized the MOIMR intervention and the sample of participants whom we 
recruited.  In the present study, drop-out rates were also higher in those locales 
where the groups had only recently been established (e.g., 86%).  In those locations 
where the groups had been running longer, fewer people dropped out of the study 
(e.g., 36%). 
 
The aim of the Moving On In My Recovery programme is to target participants who 
are relatively stable in their recovery and those who have already achieved 
abstinence.  The objective is to assist these participants in maintaining their 
abstinence and possibly exit from treatment when doing so seems feasible.  The 
actual three-month abstinence rates upon entering the study were somewhat lower 
than expected at 54% of the sample.  These rates had improved at the post-group 
timepoint (i.e., to 62%) and had improved still further at the three-month follow-up 
(68%).  Given the acceptance-based and behavioural features of the intervention, it 
is possible that some of participants were not entirely suitable for the intervention.   
 
There were no demographic or functioning differences between those participants 
who were retained in the study (i.e., the Completers) and those who dropped out 
(i.e., the Non-completers).  The implication is that the Completers were 
representative of the entire sample.  Participants who were retained in the study 
engaged in the follow-up interviews and were fully compliant on completing the 
assessment measures.  This was less easily achieved with the participants who had 
dropped out of the MOIMR programme but who were contacted at the follow-up.  In 
the main, the participants who dropped out did so because they had relapsed (i.e., 
had resumed their substance use at a dependent level) or because they had 
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continued to use substances at dependent levels.  The quality of these participants’ 
answers on the questionnaires and their ability to participate in interviews was 
greatly impaired as a consequence.  
 
The outcome measures selected for the study reasonably captured the changes 
expected from this intervention, and they were easy enough for the participants to 
complete.  The recovery capital of participants and their level of low mood and 
anxiety all improved from baseline to the post-group time-point, and these 
improvements were maintained at the three-month follow-up.  Social functioning, 
connection to values (a subscale of the AAQ-SA), and experiential avoidance all 
showed significant improvements, but only at the three-month follow-up. This might 
be as a consequence of a lack of sufficient power in the study to detect 
improvements but also theoretically, these aspects of improvement require 
significant behavioural changes; therefore, they might take greater practice and more 
time to achieve.  The intervention specifically targeted psychological flexibility. 
Although there were promising outcomes on some of these measures, significant 
changes were not detected on the acceptance scale of the AAQ-SA, even though 
the mean scores were in the expected direction.   
 
The service users’ perspective of the intervention was highly positive.  All of the 
participants who were interviewed praised the programme highly, and some of those 
who dropped out indicated that they intended to join a group in the future.  The 
participants particularly valued the co-facilitation of groups by people with lived 
experiences.  Interestingly, many participants described their initial reluctance to 
attend a group-based intervention, but also how their reticence about groups lifted as 
they became more comfortable in the group setting.  Participants described being on 
a shared journey with other group members and even with the facilitators.  It seems 
that the structure and framework of the group was something that had been missing 
from the lives of the people struggling with addiction.  The group made profound 
impacts on the participants’ lives, and many felt it should be more widely available 
and as a form of continuous support for people in recovery.  In short, participants 
were transformed from being reticent about group treatment to being champions of it.    
Conclusions and Recommendations 
 
• The Moving On In My Recovery programme is a viable intervention for a larger 
randomised control effectiveness trial. 
• The measures used in the study were acceptable to participants. 
• Recruitment into groups that have previously been established within a service 
location are likely to have better retention rates than newly established group 
programmes. 
• Service users’ involvement in the research process is highly valued and 
recommended for future endeavours. 
• Moving On In My Recovery appears to have good ecological validity and 
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Appendix A – Session List 
No. Name Aim Activity 
1 
The Next Step in 
My Recovery 
Introduce programme outline 
expectations. 






Understand psychological system 
and what gives us stability. 






Understand what can undermine 
wellbeing and actively protect it 
Protecting mental wellbeing 




Understand anxiety, learn to 
cope or seek advice; develop and 
use skills to deal with it. 
Coping strategies in the top 




Understand low mood and learn 
how to cope or seek advice for it; 
develop and use skills to deal 
with it 
Activity scheduling as the 




Door to Relapse 
Understand how and why it 
occurs and to take steps to 
lessen individual risks. 
Look at own high-risks and 
plan to minimise or avoid 
these. 
7 Peer Support 
Understand the value of peer 
support; consider how one gives 
and / or receives it. 
Committing to doing 
something for others or 





Understanding how relationships 
are important and what makes 
them toxic 
Strengthening relationships 
and building positive 
networks 
9 Being Me 
Understanding why I am who I 
am and gaining flexibility around 
it.  
Looking at the roles we all 
play and developing 





To understand the process of loss 
and use acceptance skills to get 
through the pain 
Use acceptance and 
normalisation to understand 
and cope with losses in life 
11 Stigma and Me 
Understand the cost of self-
stigma and to take steps to be 
more self-compassionate   
Develop a level of self-
compassion to let go of self-
stigma using mindfulness  
12 
More Steps in 
My Recovery 
Take stock of and celebrate 
achievements and to assess 
progress. To say goodbye  
Review sessions. Re-assess 
progress. Set goals. Say 
goodbye with a letter. 
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Appendix B – Group Process Form 
WEEK No._________      DATE__________ 










Introductions Did you name check everyone?    
Outline Did you explain the focus of today’s session?    
Check In 
Did you check with how each person had been in 
the previous week?  
   
Did you review each person’s weekly challenge?    
Did you connect the progress made to skills 
learned and content of previous sessions? 
   
Formula for 
Success 
Did you make reference to the formula for 
success? 
















Did you recognise the gains made; support the 
disclosure of sensitive material; normalise 
struggles? 
   
Empathy 
Did you reflect your understanding to 
participants appropriately - including with body 
(nodding etc)? 
   
Discussion 
Did you let people talk about relevant issues and 
draw on the experiences of other people in the 
group? 
   
Time 
Management 
Was the pacing Okay? Did you cover all the 
material?  Was there enough time for the weekly 
challenge? 
   
Managing 
Contributions 
Did everyone contribute? Did you keep people on 
track? 
   
Group 
Motivation 
Is the group involved in the group process (i.e., 
are they contributing / making changes)? 
   
Participant 
understanding  
Is the group able to relate to / understand the 
material? 







Did you set the weekly challenge and encourage 
participation (eg did facilitators participate, too)? 
   




Appendix C Interview Protocol 
Qualitative Interview Protocol  
 
What we want to do is to have a brief chat in which I will ask you a few questions about your 
experience of being involved in MOIMR. I am looking to hear from you as much as possible, 
so I will keep the questions brief. Please feel free to say what you think is important. 
Before we start, may I record this interview to allow us to analyse the data? The contents of 
this interview will normally be shared only within the research team for research purposes.  
Your name will be anonymous in any report that we produce.  
All of your responses will remain confidential, however, there are times when we must pass 
on information; for example, if we are concerned about your wellbeing or we think that 
someone is at risk of harm. 
 
If you feel you do not want to answer a particular question, or stop the interview, that is 
completely fine. 
Do you have any questions before we begin recording? 
Just for the tape, am I ok to ask you to repeat what you said? 










































Non-completers of MOIMR Interview Protocol 
 
Thank you for agreeing to be interviewed by us about your experiences of attending the 
Moving On In My Recovery Programme.  We would like to ask you some questions about 
what it was like for you.  Of course, there are no right or wrong answers and you can be re-
assured that your responses will remain strictly confidential. 
 
First, can you tell me how many group sessions did you attend? 
 
When you agreed to participate in the programme how much did you know about it? 
 






Ensure participant previously read the 
information sheet and provided written consent 
before beginning the interview. 
Remind participant of the interview purpose, and 
check that they are happy to proceed. 
Explain issues around consent including consent 
to be recorded and ensure confidentiality. 
Make sure the participant is able to ask 
questions. 
Begin Recording State participant number and gain verbal consent 





Use probes as 
Needed. 
 
Could you please tell me about your experience 
of being involved in Moving On In My 
Recovery (MOIMR)? 
How has this group impacted on your overall 
recovery experience? 
More specifically, what aspects of this recovery 
group have been important for your 
recovery? 
To your knowledge, how is this group different 
from mutual aid and 12-step groups such as 
SMART, NA and AA? 
To your knowledge, how is this group similar to 
mutual aid and 12-step groups such as SMART, 
NA and AA? 
Example probes: 
Could you please give an example? 
Is there anything else? 
Could you expand on that please? 




Let them know that you have asked all your 
questions. Then give them the 
opportunity to add anything they think might be 
important or valuable: 
‘Is there anything else you would like me to 
know or that you think is important to help us 
understand your experience better? 
In closing the interview, ensure the participant 
has time to ask any further questions. 
Debrief interview, and explain that a full verbal 
and written debrief will be provided at the end of 
the study after completing the questionnaire. 
30 
 
What did you expect you might get from participating? 
 
Please can you tell me about your experience of being involved in Moving On In My 
Recovery (MOIMR) Group? 
 
What did you see as the benefits of attending? 
 
What did you see as the barriers of attending? 
 
Can you please tell us why you decided not to keep attending the Moving On In My 
Recovery (MOIMR) programme? 
 
What are the barriers that might prevent a person to not want to complete the Moving On In 
My Recovery (MOIMR) programme? 
 
Is there anything that make you more likely to complete the Moving On In My Recovery 
(MOIMR) programme? 
 
Is there anything you would like to tell us or add? 
 
Many thanks for your time. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
